Recall Atlas
Drugs & medicalClass II

Sofie Co dba Sofie recalls Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial, Diagnostic-For Intravenous Use Only,…

Lack of Assurance of Sterility: out-of-specification test results observed for Filter Integrity Test (FIT).

Read the official notice →
Date
2023-10-04
Country
United States
Brand
Sofie Co dba Sofie
Product
Florbetaben F-18 (Neuraceq¿) Injection Solution 1.4 to 135 mCi/mL, 50 mL in 1 multi-dose glass vial, Diagnostic-For Intravenous Use Only,…
Classification
Class II
Units
Product was released to one facility in VA.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2023-10-04
  2. US
    Drugs & medicalClass II

    Ambu Inc. recalls Ambu aView 2 A Monitor-The Ambu aView 2 Advance is intended to display live imaging data from compatible Ambu visualization devices,…

    Multiple impacts, for example from being dropped, can cause to the Ambu aView 2 Advance to short-circuit and under special circumstances make the lithium-ion battery in the device combust leading to smoke and flames

    FDA · DeviceAmbu Inc.NationwideOfficial notice →
  3. US
    Drugs & medicalClass III

    RB Health (US) LLC recalls Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per…

    Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.

    FDA · DrugRB Health (US) LLCUSA nationwideOfficial notice →
  4. US
    Drugs & medicalClass III

    Tolmar, Inc. recalls Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC…

    Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

    FDA · DrugTolmar, Inc.Nationwide in the US.Official notice →
  5. 2023-09-27
  6. US
    Drugs & medicalClass II

    B. Braun Medical, Inc. recalls Perifix¿ / Epidural anesthesia set, medicated

    Product may be mislabeled with an incorrect lid stock label.

    FDA · DeviceB. Braun Medical, Inc.US Distributions to states of - AR, AZ, CA, FL, GA, IL, MA, MO, NC, NJ, PA,…Official notice →
  7. US
    Drugs & medicalClass II

    O&M HALYARD, INC. recalls FLUIDSHIELD 3 N95 Particulate Filter Respirator and Surgical Mask with SO SOFT* Lining, Orange, size small, Product Code 46827

    One respirator sample failed a filtration efficiency test. This respirator may not provide adequate protection to the user.

    FDA · DeviceO&M HALYARD, INC.US Distribution to States of: FL, GA, IA, IL, MO, MS, NE, OK, TN, TX, WI and…Official notice →
  8. US
    Drugs & medicalClass II

    Remote Diagnostic Technologies Ltd. recalls Philips Tempus Pro Patient Monitor, REF: 00-1004-R, 00-1007-R, 00-1024-R, 00-1026-R, 00-1004, and 00-1007, when Used With…

    Full screen error message may occur on patient monitors with affected hardware version, either during or after laryngoscopes are unplugged from monitors, informing users a 60-100 second shutdown/restart are required.…

    FDA · DeviceRemote Diagnostic Technologies Ltd.US:AZ, AL, CA, CO, DC, DE, FL , GA, HI, IA, ID, IL, IN , KS, KY, MA , MD , ME,…Official notice →
See all drugs & medical recalls →